Mark J. Mogul
Expertise in
4
conditions
Expertise in
4
conditions

Overview

Mark Mogul is a Hematologist and an Oncologist practicing medicine in Orlando, Florida.

Dr. Mogul is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Langerhans Cell Histiocytosis, Ependymoma, Histiocytosis, Reticulohistiocytoma, and Bone Marrow Aspiration.

He is actively involved in clinical research, co-authoring 5 peer reviewed articles and participating in 50 clinical trials. Dr. Mogul is currently accepting new patients.

Specialties

Hematology
Oncology

Licenses

Pediatrics in CA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Florida Blue
  • EPO
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
View 2 Less Insurance Carriers -

Locations

Orlando Health Arnold Palmer Hospital for Children Haley Center Children's Cancer & Blood Disorder
92 W Miller St, Orlando, FL 32806

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


50 Clinical Trials

Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
A Comprehensive Approach to Improve Medication Adherence in Pediatric ALL
A Phase 2 Study of Inotuzumab Ozogamicin (NSC# 772518) in Children and Young Adults With Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL)
A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
View 8 Less Clinical Trials
Similar Doctors
Expertise in
27
conditions
Hematology | Oncology | Otolaryngology
Expertise in
27
conditions
Hematology | Oncology | Otolaryngology
Referral may be required

Orlando Health Cancer Institute - Downtown Orlando

22 W. Underwood St., 
Orlando, FL 
 (0.3 miles away)
Languages Spoken:
English, French, Mandarin, Spanish
Accepting New Patients
Offers Telehealth

Jennifer Tseng, MD, hematologist/medical oncologist, is the Thoracic/Head and Neck Specialty Section leader for Medical Oncology and the associate director of Clinical Research for Medical Oncology at Orlando Health Cancer Institute.Dr. Tseng received her medical degree from Duke University School of Medicine. She completed her residency and served as assistant chief resident in internal medicine at Duke University Medical Center. She completed a fellowship in medical oncology and hematology at The University of Texas MD Anderson Cancer Center in Houston. She is board-certified in internal medicine and medical oncology and board-eligible in hematology. Dr. Tseng has received several honors and awards, including the C.D. Howe Award for clinical excellence in medical oncology and a Clinical Research Award from MD Anderson, the American Medical Women's Award, Hewlett Packard Award, the Alpha Omega Alpha Research Symposium Award from Duke University and a Beneficial-Hodgson scholarship from The Johns Hopkins University. She was also awarded Attending of the Year from the Internal Medicine Residency Program from Orlando Regional Medical Center and received the Exemplary Physician Colleague Award from Orlando Health in 2009.In addition to her clinical studies, Dr. Tseng has published research on various topics including molecular alterations in lung cancer and novel agents in the treatment of head and neck cancer. She has recently presented at the Annual Thoracic Oncology Symposium of the Puerto Rican Society of Hematology Oncology and spoke on neoadjuvant and adjuvant treatment strategies in lung cancer. Dr. Tseng is highly rated in 27 conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Lung Adenocarcinoma, and Bone Marrow Aspiration. Dr. Tseng is board certified in American Board Of Internal Medicine and American Board Of Internal Med. - Medical Oncology. Dr. Tseng is currently accepting new patients.

Expertise in
30
conditions
Hematology | Oncology
Expertise in
30
conditions
Hematology | Oncology
Referral may be required

Florida Cancer Specialists Pl

2501 N Orange Ave Ste 389, 
Orlando, FL 
 (3.9 miles away)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Sonalee Shroff is a Hematologist and an Oncologist practicing medicine in Orlando, Florida. Dr. Shroff is highly rated in 30 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Angiosarcoma, and Inflammatory Breast Cancer. Dr. Shroff is board certified in American Board Of Internal Medicine - Hematology and American Board Of Internal Medicine. Dr. Shroff is currently accepting new patients.

Expertise in
25
conditions
Hematology | Oncology
Expertise in
25
conditions
Hematology | Oncology
Referral may be required

Orlando Health Cancer Institute - Downtown Orlando

1400 S. Orange Ave., 
Orlando, FL 
 (0.2 miles away)
Languages Spoken:
English, Arabic, French
Accepting New Patients
Offers Telehealth

Omar Kayaleh, MD, serves as the medical oncology team leader for the Gastrointestinal Cancers Specialty Section and as a member of the Breast Cancer, Genitourinary Cancers, Hematology, Lymphoma/Myeloma and Thoracic/Head and Neck Cancers Specialty Sections at Orlando Health Cancer Institute. He also served as chairman of the Department of Internal Medicine as well as chief of the Hematology/ Oncology Specialty Section at Orlando Health Cancer Institute.Dr. Kayaleh received his medical degree from the University of Florida, completed a residency in internal medicine at Franklin Square Hospital in Baltimore and fulfilled a fellowship at the Medical University of South Carolina.Dr. Kayaleh is board-certified in internal medicine and in the specialties of medical oncology and hematology. He has held many offices and memberships on numerous medical staff committees, including Pharmacy and Therapeutics.He is a member of the Orange County Medical Society, Florida Medical Association, American Medical Association, American Society of Hematology, and the American Society of Clinical Oncology. Dr. Kayaleh is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Colorectal Cancer, Colorectal Cancer, and Lynch Syndrome. Dr. Kayaleh is board certified in American Board Of Internal Medicine - Hematology and American Board Of Internal Med. - Medical Oncology. Dr. Kayaleh is currently accepting new patients.

Frequently Asked Questions about Dr. Mark J. Mogul

How do I make an appointment with Dr. Mark J. Mogul?

You can book an appointment with Dr. Mark J. Mogul by calling their office at 321-841-8588. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mark J. Mogul a top-rated expert for Langerhans Cell Histiocytosis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mark J. Mogul is classified as an Advanced expert for Langerhans Cell Histiocytosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mark J. Mogul specialize in?

While Dr. Mark J. Mogul is a Hematology, they have specific expertise in Langerhans Cell Histiocytosis, Ependymoma, and Histiocytosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Mark J. Mogul participate in research or clinical trials?

Yes. Dr. Mark J. Mogul has published 5 articles and abstracts on conditions like Langerhans Cell Histiocytosis. You can view a list of Dr. Mark J. Mogul's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Mark J. Mogul accept my insurance?

Dr. Mark J. Mogul accepts most major insurance plans, including Anthem BCBS and Blue Cross Blue Shield. We recommend calling the office directly at 321-841-8588 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mogul's expertise for a condition
ConditionClose
      View All 23 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile